$2.34 Billion is the total value of HealthCor Management, L.P.'s 46 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 73.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Sell | UNITEDHEALTH GROUP INC | $42,602,000 | -51.5% | 170,830 | -42.8% | 1.82% | -41.9% |
| MDT | Sell | MEDTRONIC PLC | $30,060,000 | -68.7% | 333,330 | -60.7% | 1.28% | -62.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $28,597,000 | -52.1% | 622,210 | -8.6% | 1.22% | -42.6% |
| BDX | Sell | BECTON DICKINSON & CO | $22,977,000 | -60.9% | 100,000 | -53.7% | 0.98% | -53.1% |
| HOLX | Sell | HOLOGIC INC | $21,946,000 | -82.9% | 625,240 | -74.6% | 0.94% | -79.6% |
| HCA | Sell | HCA HEALTHCARE INC | $20,641,000 | -81.0% | 229,730 | -68.8% | 0.88% | -77.3% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $14,506,000 | -56.4% | 408,844 | -41.4% | 0.62% | -47.8% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $13,270,000 | -84.3% | 888,210 | -68.8% | 0.57% | -81.2% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $9,719,000 | -82.0% | 174,360 | -79.2% | 0.42% | -78.4% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $5,156,000 | -41.7% | 369,639 | -4.8% | 0.22% | -30.2% |
| DERM | Exit | DERMIRA INC | $0 | – | -364,227 | -100.0% | -0.20% | – |
| MDCO | Exit | MEDICINES COput | $0 | – | -75,000 | -100.0% | -0.23% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -50,280 | -100.0% | -0.23% | – |
| CVET | Exit | COVETRUS INCput | $0 | – | -500,000 | -100.0% | -0.24% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -302,290 | -100.0% | -0.26% | – |
| XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -100,000 | -100.0% | -0.36% | – |
| LLY | Exit | LILLY ELI & COput | $0 | – | -100,000 | -100.0% | -0.47% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -64,170 | -100.0% | -0.48% | – |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -463,390 | -100.0% | -0.49% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -65,860 | -100.0% | -0.51% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -322,540 | -100.0% | -0.61% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -283,520 | -100.0% | -0.66% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -133,210 | -100.0% | -1.11% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -618,550 | -100.0% | -1.15% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -168,730 | -100.0% | -1.23% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -560,900 | -100.0% | -1.26% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -9,477,799 | -100.0% | -1.43% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -408,617 | -100.0% | -1.51% | – |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -2,849,650 | -100.0% | -1.67% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -145,890 | -100.0% | -1.73% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -533,210 | -100.0% | -1.73% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -286,710 | -100.0% | -1.74% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -83,550 | -100.0% | -1.76% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -328,970 | -100.0% | -1.80% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -2,536,760 | -100.0% | -2.25% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -687,960 | -100.0% | -3.58% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -372,770 | -100.0% | -4.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.